Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
HOPE Focus is an observational study that aims at promoting research against metastatic breast cancer by means of collective research led by patients (patient-centric trial). Patients with metastatic breast cancer living in Spain will voluntarily register and fulfil their journey in the study through the study's digital tool. Mainly they are prompted to answer questionnaires about their disease and expectations, and to provide a blood sample and an archival tumor biopsy. In HOPE Focus these samples will be genomically analyzed and every patient case will be presented in a multidisciplinary molecular advisory board (MAB). The MAB will issue a plain report explaining the significance of the results and will enumerate future therapeutic options that match patient history and his genomic profile, when feasible. Finally, patients will have to answer short follow-up questionnaires twice a year for 3 years. The study data will allow us to advance implementing precision medicine to improve the management of current and specially future metastatic breast cancer patients.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentki i pacjenci mieszkający w Hiszpanii
- •Wiek co najmniej 18 lat
- •Podpisana świadoma zgoda na udział w badaniu
- •Dobry stan ogólny (możliwość wykonywania codziennych czynności)
- •Rak piersi z przerzutami, który niedawno pojawił się podczas leczenia uzupełniającego lub po pierwszej linii leczenia przerzutów
✗ Disqualifies
- •Choroby lub warunki zdrowotne, które mogą zagrozić bezpieczeństwu pacjenta
- •Niemożliwość lub niechęć do uczestniczenia w procedurach badania
- •Więcej niż 3 wcześniejsze leczenia chemioterapią lub lekami połączonymi z przeciwciałami dla raka przerzutowego
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- May 28, 2025
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
SOLTI Cancer Research Group
Barcelona, Spain
Trial contact
HOPE Focus Study Team
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.